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Spacer oligonucleotide (spoligotyping) analysis is a rapid polymerase chain reaction–based method of
DNA fingerprinting the Mycobacterium tuberculosis complex. We examined spoligotype data using a bioin-
formatic tool (sequence logo analysis) to elucidate undisclosed phylogenetic relationships and gain
insights into the global dissemination of strains of tuberculosis. Logo analysis of spoligotyping data pro-
vides a simple way to describe a fingerprint signature and may be useful in categorizing unique spoligo-
types patterns as they are discovered. Large databases of DNA fingerprint information, such as those from
the U.S. National Tuberculosis Genotyping and Surveillance Network and the European Concerted Action
on Tuberculosis, contain information on thousands of strains from diverse regions. The description of
related spoligotypes has depended on exhaustive listings of the individual spoligotyping patterns.  Logo
analysis may become another useful graphic method of visualizing and presenting spoligotyping clusters
from these databases. 
he process of DNA fingerprinting Mycobacterium tuber-
culosis  isolates provides epidemiologists with data for
investigating transmission and confirming laboratory cross-
contamination. When personnel and resources are available,
strains from all newly diagnosed cases of tuberculosis (TB) are
fingerprinted. Interpreting the data from these sentinel surveil-
lance studies can be challenging. TB can be latent for decades
before resulting in active disease. The best method for examin-
ing M. tuberculosis complex genotyping data gathered over
just a few years is still in question.
The genotyping of M. tuberculosis complex has been
undertaken in the United States in directed studies and in senti-
nel surveillance. Since 1992, M. tuberculosis complex DNA
fingerprinting for isolates has been available to U.S. Depart-
ments of Health and TB Control Offices to investigate cases of
suspected TB transmission and suspected laboratory cross-
contamination. At the same time, sentinel surveillance of
select regions was used to evaluate if genotyping every new
patient isolate from a particular region was useful. Although
direct DNA fingerprinting studies are relatively simple to
design, we are still learning how best to use in toto the large
and diverse databases generated by sentinel surveillance stud-
ies from multiple laboratories (1–7). Previous studies have
used DNA fingerprinting methods to understand the develop-
ment and spread of subspecies of the M. tuberculosis complex,
such as Mycobacterium africanum (8,9), M. bovis (10), and the
W-Beijing family (11,12).
Analyzing the spread and evolution of M. tuberculosis
complex strains is more complicated because of the long incu-
bation of disease and relatively short-term collection of data
(approximately 10 years). We examine whether bioinformatic
tools can help in analyzing the data collected. Bioinformatics
uses sophisticated analyses of large amounts of genetic infor-
mation to clarify the relationships between species, explain the
evolution of groups of genes, and assemble information from
genome sequencing projects. Bioinformatic analysis involves
searching nucleic acid or protein sequence information for pre-
viously unrecognized motifs that may signal previously unrec-
ognized regions of interest. Spoligotype analysis (13) is a form
of DNA sequencing by hybridization. Several groups have
used some of these novel analytical tools to examine M. tuber-
culosis complex genotyping (4,6,14). Sequence logo analysis
can find motifs in potentially related nucleic acid or protein
sequences (15). Logo analysis combines these data on a
graphic that illustrates the location and degree of sequence
conservation in the selected sequences. We applied sequence
logo analysis to find motifs based on the presence or absence
of specific spacer sequences. We also evaluated the usefulness
of logo analysis in examining phylogenetic relationships of the
M. tuberculosis complex direct repeat (DR) (7) locus and its
potential as a simple graphic method presenting grouped spoli-
gotyping data. 
We suggest using the sequence logo technique to under-
stand the distribution of each spacer sequence used in the spo-
ligotype assay. This information is useful in improving or
redesigning the spoligotype assay by showing the degree of
differentiation achieved with each spacer sequence. 
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Approximately 5,100 isolates of M. tuberculosis complex,
predominately from patients in TB control programs in the
northeast United States, are part of the Wadsworth Center spo-
ligotype database. Most of these strains have been collected
through ongoing sentinel surveillance projects in Massachu-
setts and New York City from 1996 to the present. In our strain
collection, 920 different spoligotype patterns were identified.
DNA Fingerprinting Analyses
Spoligotype analysis was performed according to a stan-
dard method (13). PCR amplifications were performed on
extracted DNA or cell suspensions, which were heat-killed at
80°C for 1 hr in an oven. Spoligotype patterns were analyzed
with BioImage Whole Band Analysis v3.4 software (Genomic
Solutions, Ann Arbor, MI) on a Sun Ultra10 workstation (Sun
Microsystems Inc., Santa Clara, CA). Spoligotype patterns
were given descriptive nomenclature according to the standard
method (16), along with a unique arbitrary numeric designa-
tion by the Centers for Disease Control and Prevention (CDC).
IS6110-based restriction fragment length polymorphism
(RFLP) analysis was performed, according to standard proto-
col (17), at the Wadsworth Center (Albany, NY) and the Public
Health Research Institute (New York City, NY), on approxi-
mately 3,700 of these isolates. RFLP patterns were analyzed
with BioImage Whole Band Analysis v3.4 software (Genomic
Solutions). RFLP pattern designations for sentinel surveillance
isolates were assigned a unique arbitrary numerical designa-
tion by CDC.
Spoligologo Analysis
Spoligologo denotes the application of sequence logo anal-
ysis to spoligotype assay data. Sequence logo analysis was
originally devised as a method to find blocks of related amino
acids between protein sequences and display the information
in an intuitive visual description that illustrates both the resi-
due and the degree of conservation at each position (18). Logo
analysis has been used to look for functional and evolutionary
relationships among groups of proteins and nucleic acids (19).
Spoligologo analysis (15) was accomplished by using WebL-
ogo software from the School of the Biological Sciences at the
University of Cambridge (available from: URL: http://
www.bio.cam.ac.uk/seqlogo/).  To be compatible with WebL-
ogo, letter designations (x=hybridization, o=no hybridization
signal) were used to denote the pattern of hybridization
observed for each spoligotype pattern. Spoligotype patterns to
be compared were entered directly into WebLogo and a post-
script file of the results was generated. Logo analysis com-
pares each selected pattern against the other at the same
position. Thus, we compared hybridization to spacer 1 in the
group of selected spoligotypes, followed by analysis of spacer
2, and so on for all 43 spacers.
For convenience of illustration, two groups of isolates
were chosen for spoligologo analysis. The first set consisted of
43 strains of M. bovis (13) in our collection. The second set
was 12 low-band (exhibiting fewer than six copies of IS6110
by RFLP analysis) M. tuberculosis isolates from Vietnam-
born, Massachusetts sentinel surveillance case-patients. Viet-
namese patients are the largest foreign-born group represented
in the low-band data from Massachusetts. 
Results
Figure 1 illustrates logo analysis with spoligotyping data.
Spoligotyping identified 28 different spoligotypes associated
with M. bovis from 43 isolates in our collection. The spoligo-
types were then coded for sequence logo analysis (Figure 1A).
Letter designations were chosen for compatibility with the
WebLogo program as described in Methods. The tallest x and
o characters represent areas of absolute concordance between
the patterns chosen for analysis. Where differences occur, the
Figure 1. Logo analysis on spoligotypes associated with Mycobacte-
rium bovis. The Wadsworth Center database contains 28 unique spolig-
otypes from strains of M. bovis. Panel A illustrates the raw hybridization
data followed by the same patterns coded for logo analysis. To be com-
patible with WebLogo analysis, patterns were converted to a 43-char-
acter–long string consisting of the letters x and o. The letter x
represents a positive hybridization, and o represents no hybridization
detected for each of the 43 spacer sequences. Panel B is the graphic
output from WebLogo. Numbers in each panel represent the spoligo-
type assay spacer sequences 1–43. Panel C shows the summary
graphic of the spoligotypes by collapsing the data into a single row.
Legend: x=hybridization observed to spacer, o= no hybridization
observed to spacer, = positive hybridization in every spoligotype pat-
tern for that individual spacer sequence, = no hybridization, z=posi-
tive hybridization in >50% of the patterns, = no hybridization in >50%
of the patterns.TUBERCULOSIS GENOTYPING NETWORK
1308 Emerging Infectious Diseases  •  Vol. 8, No. 11, November 2002
ratio of those spoligotypes showing hybridization to those that
do not is represented by relative height differences of the char-
acters in that column. The resulting spoligologo (Figure 1B)
shows that spacers 20, 25, 26, and 38 are present in all 28 spo-
ligotype patterns. The absence of spacers 39–43 in these spoli-
gotype patterns is consistent with an identification of M. bovis
(13). The greatest polymorphism between the patterns appears
in spacers 3 through 16 (Figure 1B). Spoligotype patterns
probably evolve through the loss of spacer sequences through
a variety of mechanisms (7,20). We try to extrapolate back to
the hypothetical founder of these M. bovis isolates, which we
believe had spacers 1–38 and not 39–43. No isolate with this
probable M. bovis founder spoligotype has yet been observed
in the Wadsworth Center spoligotype database.
Foreign-born persons, especially those from regions with
high TB case rates, are of concern for TB transmission in the
United States (21,22). The low-band M. tuberculosis strains
from Vietnam-born patients, which we selected, produced
another spoligologo pattern (Figure 2). The ability of spoligol-
ogo analysis to collapse even a small selection of spoligotype
patterns from a select group of strains (Figure 2A) into the
possible founder spoligotype can be observed in the summary
(Figure 2C). However, additional typing methods would be
required to verify that the strains are related, rather than exhib-
iting convergent evolution of their respective spoligotypes. 
As previously suggested (5,7,23), M. tuberculosis strains
that generally contain spacers 33–43 may form a family that is
an intermediate lineage between the Beijing (11,12) and non-
Beijing M. tuberculosis strain families, such as Haarlem (2).
Discussion
Spoligotyping, microarrays, and DNA-chips are all exam-
ples of reverse-hybridization array-based assays. Although
microarrays and DNA-chips can contain thousands of bits of
data, the principle behind them is similar to that of the spoligo-
type assay, which uses a simple 1 x 43 array. Array-based
assays use reverse hybridization in which a labeled sample is
probed against a series of proteins or nucleic acids that are
bound to a solid support, such as a nylon membrane or silica.
The result for each potential binding event can be recorded as
yes or no. The binary nature of array-based assays allows the
data to be analyzed usefully with algorithms associated with
motif recognition, such as sequence logo analysis. The relative
low cost and simplicity of the spoligotype assay means it can
be performed by many laboratories and the digital nature of the
data facilitates the exchange of information among researchers.
The growth in the availability of array-based assays has
outpaced the ability of conventional software analysis pack-
ages to provide every possible method of analysis. Customized
versions of software are extremely expensive, and researchers,
who want to implement these protocols without specialized
software, lack methods of collating the large amounts of data.
Problems arise when attempts are made to judge the signifi-
cance of similar but nonidentical array data. Identifying possi-
ble families in these array patterns may be important in
understanding the evolution and spread of pathogens such as
M. tuberculosis. Our method for collapsing array-based data
can be used to find and present patterns or signature motifs in
these types of data.
As previously noted (1), cluster analysis of large RFLP
databases is difficult for a combination of reasons, including
software failure and interlaboratory variations. Digital data,
such as spoligotyping, mycobacterial interspersed repetitive
unit (24), and variable number tandem repeat analyses (25),
will probably form the basis for any large DNA fingerprinting
projects in the future (26). 
The design of large genotyping projects should include
multiple methods (2,3,10,23). Strains that cluster by one typ-
ing method must be analyzed by other methods to ensure that
the groupings represent clusters of true relatedness and not
cases of convergent evolution. 
Bioinformatic analyses, like logo analysis, may prove use-
ful in obtaining further data from the large M. tuberculosis
complex DNA typing databases already in existence. Spoligol-
ogo analysis is a graphic method of presenting similar spoligo-
types that may elicit useful insights into the geographic spread
of tuberculosis. Potential families of TB strains could be iden-
tified on the basis of their logo; these strains could then be ana-
lyzed by additional DNA-typing methods to confirm the
relationship, followed examining relevant patient data (e.g.,
country of birth).  A similar analysis was performed for the M.
tuberculosis W-Beijing family (11) that helped elucidate the
Figure 2. Logo analysis on nine different spoligotypes observed for
Mycobacterium tuberculosis isolates from Vietnam-born patients in
Massachusetts demonstrating fewer than six copies of IS6110 by RFLP
analysis. Legend: x= hybridization observed to spacer, o= no hybridiza-
tion observed to spacer, = positive hybridization in every spoligotype
pattern for that individual spacer sequence, = no hybridization,
z=positive hybridization in >50% of the patterns, = no hybridization
in >50% of the patterns.Emerging Infectious Diseases  •  Vol. 8, No. 11, November 2002 1309
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evolution of a multidrug–resistant strain in New York City.
Spoligologo analysis could help identify more of these fami-
lies, determine their global origin, and evaluate their spread. 
Determining the sources and spread of tuberculosis is an
important tool in preventing further infections. Understanding
the geographic origin of an M. tuberculosis DNA fingerprint
could be useful, especially in understanding the sources and
spread of strains in the U.S. foreign-born population, among
whom differentiating recently transmitted disease from reacti-
vation of a past exposure can be difficult.
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